ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
3,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
4,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
8,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,1,Deafness,Hearing losses,Hearing disorders,Ear,N
11,1,Deafness,Hearing losses,Hearing disorders,Ear,N
11,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
11,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
12,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
13,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
15,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,1,Deafness,Hearing losses,Hearing disorders,Ear,N
17,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
18,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
19,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
20,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
20,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
20,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
22,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
23,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
24,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
24,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
25,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
28,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
32,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
